Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Fluorodeoxyglucose F18 × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Carcinoma, Non-Small-Cell Lung 7 Uterine Cervical Neoplasms 5 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Colonic Neoplasms 3 Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Kidney Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 von Hippel-Lindau Disease 1 Vaginal Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Oropharyngeal Neoplasms 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡